Truvestments Capital’s Clorox CLX Stock Holding History

Truvestments Capital’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.32M	Sell	24,283 -1,957	-7%	-$188K	0.34%	72
2026 Q1	$2.72M	Buy	26,240 +4,966	+23%	+$563K	0.49%	52
2025 Q4	$2.15M	Sell	21,274 -3,406	-14%	-$370K	0.39%	74
2025 Q3	$3.04M	Buy	24,680 +4,190	+20%	+$520K	0.55%	57
2025 Q2	$2.46M	Buy	20,490 +263	+1%	+$35.1K	0.49%	60
2025 Q1	$2.98M	Buy	+20,227	New	+$3.09M	0.65%	54
2022 Q1	–	Sell	-55	Closed	-$10K	–	251
2021 Q4	$10K	Buy	55 +1	+2%	+$167	0.01%	399
2021 Q3	$9K	Hold	54	–	–	0.01%	390
2021 Q2	$10K	Sell	54 -96	-64%	-$17.5K	0.01%	390
2021 Q1	$29K	Buy	150 +50	+50%	+$9.63K	0.02%	330
2020 Q4	$20K	Hold	100	–	–	0.01%	361
2020 Q3	$21K	Hold	100	–	–	0.02%	227
2020 Q2	$21K	Hold	100	–	–	0.02%	297
2020 Q1	$17K	Buy	+100	New	+$16.5K	0.02%	286
2019 Q4	–	Sell	-255	Closed	-$39K	–	228
2019 Q3	$39K	Hold	255	–	–	0.03%	298
2019 Q2	$39K	Hold	255	–	–	0.03%	314
2019 Q1	$41K	Buy	+255	New	+$39.6K	0.03%	313
2018 Q3	$63K	Buy	+419	New	+$59.5K	0.03%	338

Other funds holding CLX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Truvestments Capital's CLX Position: Q2 2026 in Review

Truvestments Capital reduced its Clorox (CLX) stake by 7.5% in Q2 2026, selling an estimated $188K and leaving 24,283 shares worth $2.32M. The position accounts for 0.34% of the portfolio, ranked #72.

Truvestments Capital first reported a position in CLX in Q3 2018 and has held it in 18 quarters since. The position peaked at $3.04M in Q3 2025. 1,046 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

Truvestments Capital held 24,283 shares of Clorox worth $2.32M as of Q2 2026.
Truvestments Capital sold 1,957 Clorox shares in Q2 2026, an estimated $188K.
Clorox made up 0.34% of Truvestments Capital's portfolio in Q2 2026, its #72 holding.
Truvestments Capital first reported a position in Clorox in Q3 2018 and has held it in 18 quarters since.
Truvestments Capital's Clorox position peaked at $3.04M in Q3 2025.
1,046 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.